Expanding Medication-Assisted Therapies in Central Asia
Recruiting
N/A
Interventional Study
Opioid Use Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 900 (estimated)
- Sponsor
- Yale University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Central Asia (CA) represents the most rapidly growing HIV epidemic region worldwide, concentrated in people who inject drugs (PWID) and their sexual partners, and scaling up opioid agonist therapies (OAT) in this region is the most cost-effective strategy to prevent new HIV infections, and more effective when combined with antiretroviral therapy (ART). The investigators propose to use the Network …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
i. Aim 1: The inclusion criteria for Aim 1 Consists of:
1. Quantitative surveys for PWID
1. 18 years or older
2. Meeting DSM-V criteria for opioid dependence
3. Be either treatment naïve and seeking OAT or be on OAT for \< 90 days
2. Organizational Assessments for OAT…
Contacts